{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:13:25Z","timestamp":1761167605034,"version":"build-2065373602"},"reference-count":233,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ghir.2007.05.005","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T07:45:21Z","timestamp":1184312721000},"page":"441-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Management of growth hormone deficiency in adults"],"prefix":"10.1016","volume":"17","author":[{"given":"Anna G.","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2007.05.005_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular diseases in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effect of growth hormone treatment in GH-deficient adults","volume":"i","author":"J\u00f8rgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib7","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib8","first-page":"2460","article-title":"An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women","volume":"81","author":"van den Berg","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","article-title":"The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults","volume":"41","author":"Weaver","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism","volume":"69","author":"J\u00f8rgensen","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib11","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","article-title":"Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women","volume":"281","author":"Wolthers","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib12","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2005-0553","article-title":"Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men","volume":"90","author":"Johannsson","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib13","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosteron administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib14","first-page":"561","article-title":"Androgen deficiency in women with hypopituitarism","volume":"86","author":"Miller","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib15","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jcem.87.5.8494","article-title":"Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial","volume":"87","author":"Johannsson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.2006.02648.x","article-title":"Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement","volume":"65","author":"Brooke","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI2773","article-title":"Route of estrogen replacement confers divergent effects of energy metabolism and body composition in postmenopausal women","volume":"102","author":"O\u2019Sullivan","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2007.05.005_bib18","first-page":"3956","article-title":"Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults","volume":"84","author":"Cook","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib19","first-page":"464","article-title":"A switch from oral (2mg\/day) to transdermal (50g\/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency","volume":"85","author":"Janssen","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib20","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"Verhelst","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","article-title":"Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing\u2019s disease","volume":"60","author":"Johannsson","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1995.tb01908.x","article-title":"Which adults develop side-effects of growth hormone replacement?","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin. Endocrinol."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2007.05.005_bib23","first-page":"3","article-title":"Effects of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency","volume":"3","author":"Johannsson","year":"1996","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib25","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH binding protein, body mass index, age and gender","volume":"81","author":"Johannsson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib26","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults: influence of gender and apo(a) and apoE phenotypes","volume":"15","author":"Johannsson","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2007.05.005_bib27","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women","volume":"82","author":"Burman","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib28","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib29","first-page":"2877","article-title":"Two years of growth hormone (GH) treatment increases isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib30","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment","volume":"82","author":"Attanasio","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib31","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1210\/jcem.86.10.7897","article-title":"GH is needed for the maturation of muscle mass and strength in adolescents","volume":"86","author":"Hulth\u00e9n","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib32","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","article-title":"Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study","volume":"86","author":"Koranyi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib33","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurements of serum markers","volume":"81","author":"de Boer","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults","volume":"83","author":"Drake","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib36","doi-asserted-by":"crossref","unstructured":"Invited report of a workshop. Consensus guidelines for the diagnosis of growth hormone deficiency: summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 379\u2013381.","DOI":"10.1210\/jc.83.2.379"},{"key":"10.1016\/j.ghir.2007.05.005_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib38","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/jc.2002-020430","article-title":"Adult growth hormone replacement: lessons learned and future direction","volume":"87","author":"Murray","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJM197911223012102","article-title":"Evaluation of acromegaly by radioimmunoassay of somatomedin-C","volume":"301","author":"Clemmons","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2265.1995.tb02651.x","article-title":"Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion","volume":"42","author":"Bates","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1994.tb02556.x","volume":"41","author":"Landin-Wilhelmsen","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib43","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.86.8.7731","article-title":"Abdominal visceral fat and fasting insulin are important predictors of 24-h GH release independent of age, gender, and other physiological factors","volume":"86","author":"Clasey","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib44","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.96.12.7088","article-title":"Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice","volume":"96","author":"Sj\u00f6gren","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2007.05.005_bib45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diabetes.50.7.1539","article-title":"Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism","volume":"50","author":"Sjogren","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2007.05.005_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.2000.00971.x","article-title":"Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency","volume":"52","author":"Murray","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib47","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis","volume":"87","author":"Johannsson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ghir.2007.05.005_bib49","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib50","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","article-title":"Hormonal predictors of prostate cancer: a meta-analysis","volume":"18","author":"Shaneyfelt","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ghir.2007.05.005_bib51","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly","volume":"83","author":"Swearingen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib52","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson","year":"1988","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.ghir.2007.05.005_bib54","first-page":"1","article-title":"Motality in acromegaly","volume":"34","author":"Wright","year":"1969","journal-title":"Q. J. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib55","first-page":"2069","article-title":"The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis","volume":"80","author":"de Boer","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib56","first-page":"1070","article-title":"The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study","volume":"79","author":"Valk","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib57","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajcn\/55.5.918","article-title":"Body composition in growth hormone-deficient adults","volume":"55","author":"Binnerts","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2007.05.005_bib58","first-page":"129","article-title":"A low starting dose of Genotropin in growth hormone-deficient adults","volume":"82","author":"Janssen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/j.1550-8528.1996.tb00511.x","article-title":"Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment","volume":"4","author":"L\u00f6nn","year":"1996","journal-title":"Obesity Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2265.1996.690512.x","article-title":"Comparison of methods to estimate body fat in growth hormone deficient adults","volume":"44","author":"Bosaeus","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib61","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"Gotherstrom","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib62","first-page":"3762","article-title":"Effects of 7 years of growth hormone replacement therapy in hypopituitary adults","volume":"85","author":"Chrisoulidou","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib63","first-page":"6","article-title":"A Ten-Year, Prospective Study of the Metabolic Effects of Growth Hormone Replacement in Adults","volume":"6","author":"Gotherstrom","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib64","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib65","first-page":"2373","article-title":"Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency","volume":"84","author":"ter Maaten","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2005.02343.x","article-title":"Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men","volume":"63","author":"Arwert","year":"2005","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib67","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ghir.2006.11.002","article-title":"Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response","volume":"17","author":"Svensson","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib69","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ghir.2007.05.005_bib70","first-page":"449","article-title":"Long-term growth hormone treatment in growth hormone deficient adults","volume":"125","author":"J\u00f8rgensen","year":"1991","journal-title":"Acta Endocrinol."},{"issue":"Suppl 4","key":"10.1016\/j.ghir.2007.05.005_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000181585","article-title":"Skeletal muscle performance in adults with growth hormone deficiency","volume":"33","author":"Cuneo","year":"1990","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2265.1995.tb01872.x","article-title":"The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib73","first-page":"279","article-title":"Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency","volume":"84","author":"Janssen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib74","first-page":"41","article-title":"Quadriceps strength before and after growth hormone replacement in hypopituitary adults: relationship to changes in lean body mass and IGF-I","volume":"1","author":"Rutherford","year":"1994","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib75","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2002-020901","article-title":"Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength","volume":"88","author":"Svensson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.1997.2801076.x","article-title":"Quality of life, body composition and muscle strength in adult growth hormone deficiency; the influence of growth hormone replacement therapy for up to 3 years","volume":"47","author":"Wallymahmed","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib77","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jcem.82.12.4426","article-title":"Contractile properties and fiber type distribution of quadriceps muscles in adults with childhood-onset growth hormone deficiency","volume":"82","author":"Bottinelli","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1530\/eje.0.1410342","article-title":"Effect of 6 months of GH replacement on myosin heavy chain composition in GH-deficient patients","volume":"141","author":"Daugaard","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/cs0880067","article-title":"Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults","volume":"88","author":"Rutherford","year":"1995","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ghir.2007.05.005_bib80","first-page":"44","article-title":"Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis","volume":"81","author":"Johansson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib81","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2007.05.005_bib82","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ghir.2007.05.005_bib83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2796.1992.tb00613.x","article-title":"The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I","volume":"232","author":"Johansson","year":"1992","journal-title":"J. Int. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib84","first-page":"118","article-title":"Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset","volume":"74","author":"Kaufman","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib85","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/jc.2005-2227","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline","volume":"91","author":"Molitch","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib86","first-page":"3352","article-title":"Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo- controlled study","volume":"81","author":"Hansen","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2265.1995.tb02690.x","article-title":"Effect of growth hormone replacement on bone mass in adult onset growth hormone deficiency","volume":"42","author":"Holmes","year":"1995","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib88","first-page":"2002","article-title":"Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency","volume":"84","author":"Johansson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency","volume":"156","author":"Gotherstrom","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib90","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study","volume":"54","author":"Drake","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib92","first-page":"2143","article-title":"Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency","volume":"83","author":"Janssen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib93","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib94","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1359\/jbmr.2003.18.6.1020","article-title":"Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions","volume":"18","author":"Bolotin","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(96)00069-5","article-title":"Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men","volume":"18","author":"Bravenboer","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2007.05.005_bib96","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/JBMR.050613","article-title":"Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men","volume":"20","author":"Bravenboer","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency","volume":"137","author":"Ros\u00e9n","year":"1997","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","article-title":"Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2013a case-control study","volume":"56","author":"Vestergaard","year":"2002","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib99","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"W\u00fcster","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib101","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2265.2004.02021.x","article-title":"Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study","volume":"60","author":"Biermasz","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib102","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/endo-122-4-1397","article-title":"Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo","volume":"122","author":"Elam","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib103","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/endo.131.6.1446613","article-title":"In vivo growth hormone treatment stimulates secretion of very low density lipoproteins by the perfused rat liver","volume":"131","author":"Elam","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib104","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1210\/endo.130.6.1597147","article-title":"Effects of growth hormone on apolipoprotein B (apoB) messenger ribonucleic acid editing, and apoB-48 and apoB-100 synthesis and secretion in the rat liver","volume":"130","author":"Sj\u00f6berg","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib105","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2007.05.005_bib106","first-page":"2010","article-title":"Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency","volume":"82","author":"Cummings","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib107","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/eje.1.02105","article-title":"Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study","volume":"154","author":"Christ","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib108","first-page":"307","article-title":"Effects of GH replacement on VLDL apoB kinetics in patients with adult GH deficiency: a stable isotope study","volume":"84","author":"Christ","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib109","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1210\/jc.2003-031474","article-title":"Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study","volume":"89","author":"Christ","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review","volume":"83","author":"Carroll","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2007.05.005_bib112","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/edrv.22.4.0438","article-title":"Optimizing GH therapy in adults and children","volume":"22","author":"Drake","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2007.05.005_bib113","series-title":"Growth Hormone","first-page":"149","article-title":"Effects of GH on lipid metabolism","author":"Johannsson","year":"1999"},{"key":"10.1016\/j.ghir.2007.05.005_bib114","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low density lipoprotein subclass pattern and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2007.05.005_bib115","first-page":"2448","article-title":"Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy","volume":"81","author":"O\u2019Neal","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib116","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-06-0652","article-title":"Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy","volume":"156","author":"Rizzo","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-9150(96)06015-7","article-title":"LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I","volume":"129","author":"Tan","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2007.05.005_bib118","first-page":"55","article-title":"Effects of growth hormone deficiency and therapy in adults on skeletal muscle glucose metabolism, lipid profiles and regional body composition","volume":"3","author":"Hew","year":"1996","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib119","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1054\/ghir.1999.0102","article-title":"The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy","volume":"9","author":"O\u2019Neal","year":"1999","journal-title":"Growth Horm IGF Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib120","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib121","first-page":"555","article-title":"Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity","volume":"81","author":"Hew","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib122","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2007.05.005_bib123","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2007.05.005_bib124","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle","volume":"88","author":"Bramnert","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle; its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus","volume":"i","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib126","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.50.10.2301","article-title":"Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure","volume":"50","author":"Nielsen","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2007.05.005_bib127","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1210\/jcem.87.7.8597","article-title":"The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults","volume":"87","author":"Nielsen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib128","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1210\/jcem.86.12.8096","article-title":"Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults","volume":"86","author":"Segerlantz","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib129","first-page":"1668","article-title":"Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy","volume":"83","author":"Christopher","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib130","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib131","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults","volume":"80","author":"Weaver","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib132","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years\u2019 treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults","volume":"48","author":"al-Shoumer","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib133","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1999.00595.x","article-title":"A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance","volume":"50","author":"Bulow","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib134","first-page":"3285","article-title":"Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience","volume":"82","author":"Hwu","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib135","first-page":"281","article-title":"Substrate metabolism and insulin sensitivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults","volume":"3","author":"J\u00f8rgensen","year":"1996","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib136","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Ros\u00e9n","year":"1993","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib137","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib138","first-page":"1671","article-title":"Body composition, bone metabolism, and heart structure and function in growth hormone(GH)-deficient adults before and after GH replacement therapy at low doses","volume":"77","author":"Amato","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib139","first-page":"E219","article-title":"Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement","volume":"267","author":"Cittadini","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2007.05.005_bib140","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency","volume":"98","author":"B\u00f6ger","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2007.05.005_bib141","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","article-title":"Cardiovascular and renal effects of growth hormone","volume":"40","author":"Caidahl","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib142","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2265.1994.tb01827.x","article-title":"Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults","volume":"41","author":"Thuesen","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib143","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2007.05.005_bib144","first-page":"1881","article-title":"Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency","volume":"83","author":"Sverrisdottir","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib145","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ghir.2007.05.005_bib146","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/00004872-200310000-00018","article-title":"The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults","volume":"21","author":"Sverrisdottir","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ghir.2007.05.005_bib147","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2265.2003.01832.x","volume":"59","author":"Leonsson","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib149","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jcem.82.5.3951","article-title":"Increased arterial intima-media thickness in childhood-onset growth hormone deficiency","volume":"82","author":"Capaldo","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib150","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib151","doi-asserted-by":"crossref","unstructured":"M. Pfeifer, M. Verhovec, B. Zi Zek, J. Pre Zelj, P. S.P., R.N. Clayton, Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults, J. Clin. Endocrinol. Metab. 84 (1999) 453\u2013457.","DOI":"10.1210\/jc.84.2.453"},{"key":"10.1016\/j.ghir.2007.05.005_bib152","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","article-title":"Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study","volume":"56","author":"Smith","year":"2002","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib153","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1210\/jc.2003-030223","article-title":"Growth hormone increases vascular cell adhesion molecule 1 expression: in vivo and in vitro evidence","volume":"89","author":"Hansen","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib154","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2006.02518.x","article-title":"Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency","volume":"64","author":"Gomez","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib156","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/01.CIR.0000129763.51060.77","article-title":"Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals","volume":"109","author":"Randeva","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2007.05.005_bib157","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM196201112660207","article-title":"Clinical use of human growth hormone","volume":"266","author":"Raben","year":"1962","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib158","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/jcem.80.12.8530603","article-title":"Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial","volume":"80","author":"Burman","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl A","key":"10.1016\/j.ghir.2007.05.005_bib159","first-page":"43","article-title":"Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials","volume":"1","author":"M\u00e5rd","year":"1994","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7525-3-63","article-title":"Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis","volume":"3","author":"Deijen","year":"2005","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ghir.2007.05.005_bib161","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ghir.2005.09.001","article-title":"The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis","volume":"15","author":"Arwert","year":"2005","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib162","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib163","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.1999.00722.x","article-title":"Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults","volume":"50","author":"Murray","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib164","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jcem.86.8.7709","article-title":"A prospective investigation of quality of life and psychological well-being following the discontinuation of growth hormone (GH) treatment in adolescent patients who had GH deficiency during their childhood","volume":"86","author":"Wir\u00e9n","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib165","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.1998.00462.x","article-title":"Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency","volume":"48","author":"Wir\u00e9n","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib166","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02176","article-title":"Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?","volume":"155","author":"Koltowska-Haggstrom","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib167","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib168","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000093337","article-title":"Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study","volume":"83","author":"Arwert","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib169","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.psyneuen.2006.01.005","article-title":"The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature","volume":"31","author":"Falleti","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2265.2006.02555.x","article-title":"Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy","volume":"65","author":"Peker","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib171","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-121-7-199410010-00002","article-title":"Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly","volume":"121","author":"Grunstein","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib172","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-115-7-527","article-title":"Sleep apnea in acromegaly","volume":"115","author":"Grunstein","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib173","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00019053-200017060-00008","article-title":"Cost of illness in adult patients with hypopituitarism","volume":"17","author":"Ehrnborg","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ghir.2007.05.005_bib174","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1210\/jcem.86.11.7997","article-title":"Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency","volume":"86","author":"Hernberg-Stahl","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2003.12.001","article-title":"Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption","volume":"14","author":"Svensson","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib176","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1530\/eje.1.02149","article-title":"Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults\u2014comparison between Sweden, The Netherlands and Germany","volume":"154","author":"Saller","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib177","doi-asserted-by":"crossref","unstructured":"Consensus, Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society, J. Clin. Endocrinol. Metab. 86 (2001) 1868\u20131870.","DOI":"10.1210\/jc.86.5.1868"},{"key":"10.1016\/j.ghir.2007.05.005_bib178","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959\u201385: a cohort study","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib179","first-page":"1420","article-title":"Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality","volume":"85","author":"Nilsson","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib181","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","article-title":"Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients","volume":"66","author":"Agha","year":"2007","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib182","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","article-title":"Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: Studies in GH-deficient adults","volume":"41","author":"J\u00f8rgensen","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib183","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib184","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2265.1996.671492.x","article-title":"The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood","volume":"44","author":"Nicolson","year":"1996","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000182734","article-title":"Discontinuing of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance","volume":"39","author":"Colle","year":"1993","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib186","first-page":"4516","article-title":"Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children","volume":"84","author":"Johannsson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib187","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2265.1991.tb00327.x","article-title":"Changes in skeletal muscle and body composition after discontinuing of growth hormone treatment in growth hormone deficient adults","volume":"34","author":"Rutherford","year":"1991","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/1650197719894553","article-title":"Isometric and isokinetic knee extension and flexion torque in men and women aged 20\u201370","volume":"21","author":"Borges","year":"1989","journal-title":"Scand. J. Rehab. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib189","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/jappl.1979.46.3.451","article-title":"Muscle strength and speed of movement in relation to age and muscle morphology","volume":"46","author":"Larsson","year":"1979","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ghir.2007.05.005_bib190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S8756-3282(96)00312-2","article-title":"The accumulation of whole body skeletal mass in third- and fourth-grade children: effects of age, gender, ethnicity, and body composition","volume":"20","author":"Nelson","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2007.05.005_bib191","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib192","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood and adulthood: a two-year placebo-controlled study","volume":"85","author":"Vahl","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib193","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1210\/jcem.85.5.6613","article-title":"Continuation of growth hormone (GH) therapy in GH-deficient patients during transition form childhood to adulthood: impact on insulin sensitivity and substrate metabolism","volume":"85","author":"Norrelund","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib194","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/jc.2003-031588","article-title":"Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth","volume":"89","author":"Carroll","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib195","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1210\/jc.2002-021541","article-title":"The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth","volume":"88","author":"Drake","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib196","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2003-030126","article-title":"Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study","volume":"88","author":"Shalet","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib197","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","article-title":"Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial","volume":"90","author":"Mauras","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib198","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2265.2003.01949.x","article-title":"Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD","volume":"60","author":"Baroncelli","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib199","first-page":"717","article-title":"Pathophysiology of the neororegulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2007.05.005_bib200","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI110164","article-title":"Impaired growth hormone secretion in the adult population. Relation to age and adiposity","volume":"67","author":"Rudman","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2007.05.005_bib201","first-page":"460","article-title":"Beyond somatopause: growth hormone deficiency in adults over the age of 60 years","volume":"81","author":"Toogood","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib202","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2265.1996.8310842.x","article-title":"Body composition in growth hormone deficient adults over the age of 60 years","volume":"45","author":"Toogood","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib203","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jc.2006-0887","article-title":"Baseline characteristics and effects of growth hormone therapy over two years in younger and older adults with adult onset GH deficiency","volume":"91","author":"Franco","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.2004.02181.x","article-title":"The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients","volume":"62","author":"Gotherstrom","year":"2005","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib205","first-page":"4104","article-title":"Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease","volume":"85","author":"Fernholm","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib206","first-page":"1462","article-title":"Elderly patients with adult-onset growth hormone deficiency are not osteopenic","volume":"82","author":"Toogood","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib207","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2265.2004.02080.x","article-title":"The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency","volume":"61","author":"Elgzyri","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib208","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.2000.01104.x","article-title":"Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database","volume":"53","author":"Monson","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl A","key":"10.1016\/j.ghir.2007.05.005_bib209","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ghir.2004.03.013","article-title":"Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults","volume":"14","author":"Feldt-Rasmussen","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.05.005_bib210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/003655000750060904","article-title":"Muscle performance in an urban population sample of 40- to 79-year-old men and women","volume":"32","author":"Sunnerhagen","year":"2000","journal-title":"Scand. J. Rehab. Med."},{"key":"10.1016\/j.ghir.2007.05.005_bib211","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(05)73137-8","article-title":"Can growth hormone therapy cause diabetes? KIMS Strategic Committee","volume":"355","author":"Monson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib212","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2007.05.005_bib213","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib214","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1210\/jcem.86.11.8018","article-title":"Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy","volume":"86","author":"Frajese","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib215","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib216","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2005.02282.x","article-title":"Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors","volume":"62","author":"Jostel","year":"2005","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib217","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/eje.0.1500497","article-title":"Doubled mortality rate in irradiated patients reoperated for regrowth of a macroadenoma of the pituitary gland","volume":"150","author":"Erfurth","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2007.05.005_bib218","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib219","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib220","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib221","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ghir.2007.05.005_bib222","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.1999.00650.x","article-title":"Life expectancy following surgery for pituitary tumours","volume":"50","author":"Bates","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib223","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib224","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2007.05.005_bib225","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/384033a0","article-title":"Dwarf mice and the ageing process","volume":"384","author":"Brown-Borg","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2007.05.005_bib227","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1210\/endo.141.7.7586","article-title":"Assessment of growth parameters and life span of GHR\/BP gene-disrupted mice","volume":"141","author":"Coschigano","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2007.05.005_bib228","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1073\/pnas.111158898","article-title":"Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production","volume":"98","author":"Flurkey","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2007.05.005_bib229","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01298","article-title":"IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice","volume":"421","author":"Holzenberger","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2007.05.005_bib230","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1210\/jc.2002-021938","article-title":"Reduced longevity in untreated patients with isolated growth hormone deficiency","volume":"88","author":"Besson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib231","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jcem.84.11.6171-1","article-title":"Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.05.005_bib232","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ghir.2007.05.005_bib233","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.1989.00520400109029","article-title":"The effect of radiation on carotid arteries. A review article","volume":"46","author":"Murros","year":"1989","journal-title":"Arch. Neurol."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663740700072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663740700072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:43:34Z","timestamp":1761086614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663740700072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":233,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S109663740700072X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2007.05.005","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of growth hormone deficiency in adults","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2007.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}